Khan Yasmine, Van den Borre Laura, Smedt Delphine De, Verhaeghe Nick, Devleesschauwer Brecht, Deboosere Patrick, Vanthomme Katrien, Gadeyne Sylvie
Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Cancer Med. 2025 Jan;14(1):e70487. doi: 10.1002/cam4.70487.
The COVID-19 pandemic disrupted global health systems, impacting cancer care and potentially increasing cancer mortality, especially among socioeconomically disadvantaged individuals. We aimed to assess changes in cancer mortality from March 1 to December 31, 2020 relative to the same period in 2019, and to examine potential shifts in cancer mortality's social disparities during the same time frame.
We used nationwide individually linked cancer mortality data from the Belgian National Register, the Census 2011, and the tax register. Analyses were stratified by age group (45-59 years, 60-74 years, 75+ years) and sex across all cancer types, including breast, colorectal, lung, pancreatic, and prostate. Direct age-standardized mortality rates were calculated in 2019 and 2020 to calculate absolute and relative changes in cancer mortality by social indicators. Relative inequalities in cancer mortality by social groups were calculated for both time frames using Poisson regression. Sensitivity analysis considered any mention of specified cancer groups on the Belgian death certificate.
For both overall and site-specific cancers, our study found decreases in cancer mortality during the pandemic's early stages, particularly among individuals aged 75 and older. These changes did not significantly alter established socioeconomic patterns in cancer mortality.
Reductions in reported cancer deaths in 2020 may reflect COVID-19 prioritization in cause-of-death coding and its role as a competing risk, rather than true declines. Persistent educational disparities emphasize the need for continued policy and healthcare collaboration, with future research focused on the pandemic's long-term effects on cancer mortality and social inequalities.
新冠疫情扰乱了全球卫生系统,影响了癌症治疗,并可能增加癌症死亡率,尤其是在社会经济弱势群体中。我们旨在评估2020年3月1日至12月31日期间癌症死亡率相对于2019年同期的变化,并研究同一时期癌症死亡率社会差异的潜在变化。
我们使用了来自比利时国家登记册、2011年人口普查和税务登记册的全国个体关联癌症死亡率数据。分析按年龄组(45 - 59岁、60 - 74岁、75岁及以上)和性别对所有癌症类型进行分层,包括乳腺癌、结直肠癌、肺癌、胰腺癌和前列腺癌。计算2019年和2020年的直接年龄标准化死亡率,以按社会指标计算癌症死亡率的绝对和相对变化。使用泊松回归计算两个时间框架内不同社会群体癌症死亡率的相对不平等。敏感性分析考虑了比利时死亡证明上对特定癌症组的任何提及。
对于总体癌症和特定部位癌症,我们的研究发现疫情早期癌症死亡率有所下降,尤其是在75岁及以上的人群中。这些变化并未显著改变癌症死亡率既定的社会经济模式。
2020年报告的癌症死亡人数减少可能反映了新冠在死因编码中的优先级及其作为竞争风险的作用,而非真正的下降。持续存在的教育差距凸显了持续开展政策和医疗合作的必要性,未来的研究应聚焦于疫情对癌症死亡率和社会不平等的长期影响。